Demographic and clinical details
| Normal SCJ no inflammation (n = 12) | Normal SCJ with inflammation (n = 14) | BO (n = 12) | OAC (n = 12) | SSBO (n = 10) | IMNSCJ (n = 14) | |
|---|---|---|---|---|---|---|
| Values are median (range) or percentage. | ||||||
| BO, Barrett’s oesophagus; IMNSCJ, intestinal metaplasia at a normal squamo–columnar junction; OAC, oesophageal adenocarcinoma; SCJ, squamo–columnar junction; SSBO, short segment Barrett’s oesophagus. | ||||||
| Age (years) | 46 (25–72) | 48 (26–66) | 66 (47–78) | 65 (55–80) | 58 (29–90) | 59 (35–81) |
| Male | 58% | 50% | 75% | 67% | 30% | 36% |
| Length of columnar segment (cm) | 0 (0–1) | 0 (0–2) | 5 (3–10) | − | 1 (1–2) | 0 |
| Helicobacter pylori infection | 0% | 86% | − | − | 40% | 79% |
| Proton pump inhibitor treatment | 17% | 29% | 58% | – | 20% | 14% |